Search

everythinglearnresearchcommunity

for

Search:↓

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

Hair follicle stem cells can become melanocytes to help treat skin depigmentation.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Scalp pemphigus vulgaris can be effectively treated with low-dose prednisone and triamcinolone.

The LTF gene may help predict and manage nonspecific orbital inflammation.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

A new therapy for a skin blistering condition has not been developed yet.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

Multiphoton microscopy can effectively detect early endometrial cancer by analyzing collagen changes.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Androgenetic alopecia in women may be improved by targeting oxidative stress, inflammation, and fibrosis.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Restoring hair follicle immune privilege may help treat alopecia areata.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

A rare skin condition in a boy is likely due to a specific genetic mutation pattern.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

The model can effectively test gene functions and drug responses in human skin.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.